David Wurtman - Oct 13, 2021 Form 3 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Chief Medical Officer
Signature
David Wurtman
Stock symbol
LUCD
Transactions as of
Oct 13, 2021
Transactions value $
$0
Form type
3
Date filed
10/13/2021, 09:28 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LUCD Employee stock option (right to buy) Oct 13, 2021 Common stock 706K $0.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options consist of: (i) 423,300 options granted February 18, 2019, 282,200 vesting upon grant and the rest vesting in twelve equal quarterly installments from March 31, 2019 to December 31, 2021, all 423,300 expiring February 18, 2029; and (ii) 282,200 options granted August 19, 2019, vesting in twelve equal quarterly installments from September 30, 2019 to June 30, 2022, and expiring August 19, 2029.